| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 12/29/2004 | CN1557415A Medicine preparation for treating liver and gallbladder disease and its preparing process |
| 12/29/2004 | CN1557409A Medicinal composition for treating inflammation and ulcer of stomach and duodenum |
| 12/29/2004 | CN1557399A Prescription for treating cholecystolithiasis |
| 12/29/2004 | CN1557396A Chinese medicinal composition for treating hepatitis B |
| 12/29/2004 | CN1557367A Chinese medicinal dietotherapy prescription for treating anus and intestines disease |
| 12/29/2004 | CN1557364A Liver disease treating and liver clearing Chinese traditional medicine |
| 12/29/2004 | CN1557354A Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process |
| 12/29/2004 | CN1557353A Preparing and quality controlling method of Chinese traditional medicine composition |
| 12/29/2004 | CN1557348A Bolus of pseudostellaria root and antelope horn for melting calculi |
| 12/29/2004 | CN1557343A Yin-nourishing and heat-clearing, mental anxiety easing preparation |
| 12/29/2004 | CN1557341A Preparing process of multiple biologically active substance containing formulation |
| 12/29/2004 | CN1557340A Growth factor and immuneglobin preparation |
| 12/29/2004 | CN1557339A Preparation for preventing and treating tympanitis and dental caries |
| 12/29/2004 | CN1557327A Adefovir dipivoxil and polyethylene glycol fused matter and its preparation method |
| 12/29/2004 | CN1557323A Diammonium glycyrrhizinate powder injection and its preparation method |
| 12/29/2004 | CN1557311A Fibrauretine capsule tablet and its preparation method |
| 12/29/2004 | CN1557306A Flavescent sophora root essence dispersion tablet |
| 12/29/2004 | CN1557305A Matrine drop pills and its preparation method |
| 12/29/2004 | CN1557303A Use of Pidotimod in preparation of hepatitis B treating medicine |
| 12/29/2004 | CN1557289A Tensicor freeze-drying formulation and its making method |
| 12/29/2004 | CN1182155C Recombinant human hepatocyte auxin, its preparing process and its clinical application |
| 12/29/2004 | CN1182149C Method for preparing glucoside in resveratrol of medicine to nourish liver and lowering fat |
| 12/29/2004 | CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 12/29/2004 | CN1181881C Stomatocace treating medicine |
| 12/29/2004 | CN1181875C Medicine for treating fat liver of obesity and its preparing method |
| 12/29/2004 | CN1181869C Oral liquid for treating gastritis |
| 12/29/2004 | CN1181856C Medicine with functions of postponing senility and loosening the bowel to relieve constipation |
| 12/29/2004 | CN1181854C Kidney and spleen invigorating Chinese medicine beverage for delaying senility |
| 12/29/2004 | CN1181849C Gastropathy treating Chinese medicine |
| 12/29/2004 | CN1181838C Medicine for treating gastroduodenal ulcer |
| 12/29/2004 | CN1181821C Lesion-aimed antibiotics in dry dosage forms for treatment of shallow ulcers of oral mucosa |
| 12/29/2004 | CA2530181A1 Novel imidazopyridine compound ii with therapeutic effect |
| 12/29/2004 | CA2529896A1 Hip/pap polypeptide composition for use in liver regeneration and for the prevention of liver failure |
| 12/29/2004 | CA2527765A1 Use of isomalt as prebiotic |
| 12/28/2004 | US6835837 Antiallergens; antiinflammatory agents; skin disorders; osteoporosis |
| 12/28/2004 | US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 12/28/2004 | US6835744 3,3-substituted indoline derivatives |
| 12/28/2004 | US6835740 Methods for treating sleep apnea and sleep induced apnea using optically pure (+) norcisapride |
| 12/28/2004 | US6835738 Phenylalanine enamide derivatives |
| 12/28/2004 | US6835737 Quinoline inhibitors of cGMP phosphodiesterase |
| 12/28/2004 | US6835731 Chemokine receptor binding heterocyclic compounds |
| 12/28/2004 | US6835730 4-heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof |
| 12/28/2004 | US6835727 Bone disorders; osteoporosis; rheumatic diseases |
| 12/28/2004 | US6835716 Bactericides, antiprotozoa agents |
| 12/28/2004 | US6835711 Use of poly-Glu,Tyr for neuroprotective therapy |
| 12/28/2004 | US6835376 Lactobacillus paracasei strain for preventing diarrhea caused by pathogenic bacteria |
| 12/28/2004 | US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery |
| 12/28/2004 | CA2226039C Pyridylfuran and pyridylthiophene compounds |
| 12/23/2004 | WO2004111038A1 5,6-bis (4-chlorophenyl)-n-piperidin1-yl-3-(piperidin-1-yl-carbonyl)pyrazine-2-carboxamide |
| 12/23/2004 | WO2004111037A1 Cyclic tertiary amine compound |
| 12/23/2004 | WO2004111033A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
| 12/23/2004 | WO2004110986A1 Benzamide derivative or salt thereof |
| 12/23/2004 | WO2004110489A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE |
| 12/23/2004 | WO2004110471A1 Preventive or remedy for disease associated with apoptosis |
| 12/23/2004 | WO2004110466A2 Pediocin-producing pediococci |
| 12/23/2004 | WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST |
| 12/23/2004 | WO2004110447A1 Use of tetrahydronaphtalene derivatives for treatment of gi disorders |
| 12/23/2004 | WO2004110446A1 Use of tetrahydronaphtalene derivatives for the treatment of ibs |
| 12/23/2004 | WO2004110430A1 Use of substituted chromans or thiocromans for the treatment of fgd |
| 12/23/2004 | WO2004110429A1 Use of substituted chromans or thiocromans for the treatment of ibs |
| 12/23/2004 | WO2004110415A2 Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments |
| 12/23/2004 | WO2004064843A3 Compound preparation for dizziness |
| 12/23/2004 | WO2004049095A3 Betaine and salicylic acid compositions |
| 12/23/2004 | WO2003080081A3 Synergistic composition of trans-tetracos-15-enoic acid and apocynin and use thereof |
| 12/23/2004 | US20040260096 Novel substituted 4-phenyl-4-{1h-imidazol-2-yl}-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 12/23/2004 | US20040260069 Modified anti-tnf aplha antibody |
| 12/23/2004 | US20040259949 Aminolevulinulic acid/5-/ and derivatives for healing wounds with heat and photosensitizers for ulcers |
| 12/23/2004 | US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 12/23/2004 | US20040259927 Compounds for treatment of sleep apnea, respiratory system disorders or kidney failure |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259905 stable, less irritant and easily administrable; high concentration of sulfodehydroabietic acid or salt ion at pH of 7-8.5 in a buffer of a polyphosphate salt or polycarboxylic acid salt such as trisodium citrate and an inorganic base such as sodium hydroxide; for inflammatory bowel disease treatment |
| 12/23/2004 | US20040259899 in patients who are refractory to laxative and stool softener treatment, such as cancer patients on opioids such as morphine, using an opioid antagonist such as methylnaltrexone and a laxative and/or stool softener |
| 12/23/2004 | US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 12/23/2004 | US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example |
| 12/23/2004 | US20040259886 Compositions and methods for treating osteoporosis and lowering cholesterol |
| 12/23/2004 | US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents |
| 12/23/2004 | US20040259865 Laxative; adenosine receptor antagonist |
| 12/23/2004 | US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof |
| 12/23/2004 | US20040259858 such as 3-(2-methyl-4-pyrrolidin-1-yl-quinolin-7-yl-methoxy)-benzonitrile; neuropeptide y receptor antagonists; for treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
| 12/23/2004 | US20040259842 Anticoagulants ; antiischemic agents; autoimmune disease; antihistamines; antiallergens; antihistamines; brain disorders; kidney disease; pancreatitis; Alzheimer's disease |
| 12/23/2004 | US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents |
| 12/23/2004 | US20040259820 Kit for delivering decitabine in vivo |
| 12/23/2004 | US20040259246 Liver cell progenitor and use for treatment of liver diseases |
| 12/23/2004 | US20040259227 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases asociated with or caused by altered metabolism of bile acids |
| 12/23/2004 | US20040259139 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 12/23/2004 | US20040258782 Isolation of lutein from alfalfa |
| 12/23/2004 | US20040258730 Sustained relase film comprises (11Apha ,13E,15 alpha )-9-oxo-11,15-dihydroxy-16-(3-methoxymethylphenyl)-17,18,19,20-tetranor-5-thiaprost-13-enoic acid methyl ester to treat bone mass disorders; osteoporosis, metastatic bone, hypercalcemia, and Paget's disease |
| 12/23/2004 | US20040258709 Hepatitis B virus polypeptides |
| 12/23/2004 | US20040258689 Augmenting activin induced signaling in cells; screening for complex inhibitors; treatment of reproductive, developmental, skin, bone, hepatic, hematopoietic and/or central nervous system disorders; prostrate cancer |
| 12/23/2004 | US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies |
| 12/23/2004 | US20040258622 Nonozone depleting aerosol formulation employing hydrofluoroalkane propellants |
| 12/23/2004 | CA2528993A1 Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
| 12/23/2004 | CA2528929A1 Cyclic tertiary amine compound |
| 12/23/2004 | CA2528883A1 Pharmaceutical compositions for preventing or treating th1-mediated immune diseases |
| 12/23/2004 | CA2527856A1 Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments |
| 12/23/2004 | CA2527033A1 2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators |
| 12/23/2004 | CA2526387A1 Benzamide derivative or salt thereof |
| 12/22/2004 | EP1489083A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 12/22/2004 | EP1489081A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient |
| 12/22/2004 | EP1489077A1 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same |